Related Experiment Video
Updated: Jul 10, 2026
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Elevated platelet beta-secretase activity in mild cognitive impairment
1Division of Psychiatry and Neuroscience, School of Medicine and Dentistry, Queen's University Belfast, Belfast, UK.
Background/Aims:
We have recently reported that platelet activity of the rate-limiting enzyme for beta-amyloid peptide production is elevated in established Alzheimer's disease. Laboratory investigation of the very early stages of dementia provides an opportunity to investigate pathological mechanisms before advanced disease hinders interpretation. Mild cognitive impairment (MCI) exists prior to obvious dementia, and is associated with increased risk of conversion to overt disease.
Methods:
We developed and used a fluorimetric assay to quantify platelet membrane beta-secretase activity in 52 patients with MCI and 75 controls.
Results:
Platelet membrane beta-secretase activity was 24% higher in individuals with MCI compared to controls (p = 0.001, unpaired t test with Welch correction).
Conclusion:
Elevated platelet beta-secretase activity in subjects with MCI is an area for further study in relation to the etiology and diagnosis of MCI.
Insights
Platelet beta-secretase activity, an enzyme linked to Alzheimer's disease, is elevated in individuals with mild cognitive impairment (MCI). This finding suggests potential diagnostic markers for early dementia stages.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Platelet activity of beta-secretase, key in amyloid peptide production, is elevated in Alzheimer's disease.
- Mild cognitive impairment (MCI) precedes dementia and indicates higher conversion risk.
- Studying MCI offers insight into early pathological mechanisms.
Purpose of the Study:
- To quantify platelet membrane beta-secretase activity in individuals with MCI.
- To compare enzyme activity between MCI patients and healthy controls.
Main Methods:
- Developed and utilized a fluorimetric assay.
- Assessed platelet membrane beta-secretase activity.
- Included 52 MCI patients and 75 controls.
Main Results:
- Platelet beta-secretase activity was 24% higher in MCI patients versus controls.
- The difference was statistically significant (p = 0.001).
Conclusions:
- Elevated platelet beta-secretase activity observed in MCI warrants further investigation.
- This finding may contribute to understanding MCI etiology and diagnosis.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
